APIC BIO
Apic Bio is a gene therapy company that develops treatment options for rare, undertreated neurological and liver diseases. The company is advancing several novel gene therapies to treat Alpha-1 Antitrypsin Deficiency (Alpha-1), genetic Amyotrophic Lateral Sclerosis (ALS), and other CNS diseases.
APIC BIO
Industry:
Biotechnology Health Care Life Science Pharmaceutical
Founded:
2017-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.apic-bio.com
Total Employee:
11+
Status:
Active
Contact:
(857) 302-3757
Total Funding:
53.32 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta SPF Google Font API LetsEncrypt SSL By Default Apache Person Schema Unified Layer Comcast
Similar Organizations
Athelas
Athelas develops technology to monitor chronically ill patients in their homes.
Biophytis
Biophytis is a research company that focuses on the fields of metabolic and age-related diseases.
Bioz
Bioz is a disruptive startup at the intersection of information technology and scientific research.
Dren Bio
Dren Bio focuses on protein engineering technologies for depletion of cells, protein aggregates, and other disease-causing agents.
GentiBio
GentiBio is a biotherapeutics company developing engineered regulatory T cells programmed to treat autoimmune allergic diseases.
New Amsterdam Pharma
New Amsterdam is a clinical-stage company focused on the research and development of transformative therapies for cardio-metabolic diseases.
NKGen Biotech
NKGen Biotech is restoring immune function through the development of unique natural killer (NK) cell therapies for the treatment of cancer.
Toregem BioPharma
Toregem BioPharma is a startup from Kyoto University that develops a treatment for congenital adentia.
VectorY
VectorY is an integrated gene therapy company focused on development of therapeutics for CNS, somatic disorders and muscle diseases.
Vigil Neuroscience
Vigil Neuroscience is a biotechnology company that develops novel therapeutics for neurodegenerative diseases.
Current Advisors List
Board_member
Board_observer
Current Employees Featured
Daniel Geffken Interim Chief Financial Officer @ Apic Bio
Interim Chief Financial Officer
2018-03-01
Christian Mueller Co Founder @ Apic Bio
Co Founder
2017-01-01
Jorge A. Quiroz Executive Vice President & Chief Medical Officer @ Apic Bio
Executive Vice President & Chief Medical Officer
2020-08-01
John Reilly Co-Founder/President & CEO @ Apic Bio
Co-Founder/President & CEO
2017-04-01
Stephen J. Hoffman Chairman @ Apic Bio
Chairman
2021-01-01
Founder
Investors List
Morningside Venture Investments
Morningside Venture Investments investment in Series A - Apic Bio
ALS Investment Fund
ALS Investment Fund investment in Series A - Apic Bio
Alpha-1 Foundation
Alpha-1 Foundation investment in Seed Round - Apic Bio
Edward Krapels
Edward Krapels investment in Seed Round - Apic Bio
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2019-01-17 | MabPlex International | Apic Bio investment in Series A - MabPlex International | 400 M CNY |
Official Site Inspections
http://www.apic-bio.com Semrush global rank: 13.36 M Semrush visits lastest month: 78
- Host name: haproxy05.parklogic.com
- IP address: 72.52.178.23
- Location: Lansing United States
- Latitude: 42.7348
- Longitude: -84.6245
- Metro Code: 551
- Timezone: America/Detroit
- Postal: 48917
More informations about "Apic Bio"
Apic Bio - Crunchbase Company Profile & Funding
Apic Bio is a gene therapy company that develops treatment options for rare, undertreated neurological and liver diseases. The company is advancing …See details»
Apic Bio Inc. - Life-Sciences-Europe.com
Jan 1, 2017 Apic Bio is an innovative gene therapy company focused on developing first-in-class treatment options for rare, undertreated neurological and liver diseases. The Company’s lead …See details»
Team - Damona Pharmaceuticals
Prior to joining Damona, Mr. Reilly served as President & CEO of Apic Bio, a gene therapy company focused on rare neurodegenerative and liver diseases. He has also served as Vice …See details»
Apic Bio 2025 Company Profile: Valuation, Funding
Apic Bio General Information Description. Operator of a gene therapy company intended to help patients find a cure for genetic diseases. The company's …See details»
Apic Bio - Funding, Financials, Valuation & Investors - Crunchbase
Jan 17, 2019 Apic Bio is funded by 4 investors. Morningside and ALS Investment Fund are the most recent investors. Apic Bio has invested in MabPlex International on Jan 17, 2019. This …See details»
Apic Bio - Contacts, Employees, Board Members, Advisors & Alumni
Apic Bio has 5 current employee profiles, including Interim Chief Financial Officer Daniel Geffken. Apic Bio has 2 board members and advisors, including Jason Dinges. Contacts. Edit Contacts …See details»
Apic Bio Company Profile - Office Locations, Competitors ... - Craft
Apic Bio is a gene therapy company that is engaged in finding cures for patients with devastating neurological and liver genetic diseases. The Company's pipeline focuses on treatments for …See details»
Apic Bio, Inc. Overview | SignalHire Company Profile
The position of the Co-Founder & CEO is occupied by John Reilly. Its headquarters is located at Cambridge, Massachusetts, USA. The Apic Bio, Inc. annual revenue is estimated at < 1M. …See details»
Apic Bio Announces FDA Clearance of IND Application for Lead …
Apr 22, 2021 Apic Bio is an innovative gene therapy company focused on developing first-in-class treatment options for rare, undertreated neurological and liver diseases. The Company’s …See details»
Executive Assistant & Office Manager at Apic Bio - The …
Brooke specializes in classical technique, but also teaches across genres. In 2021, they began working as an Executive Assistant and Office Manager at Apic Bio, Inc. Prior to this, they worked at Ohana Biosciences, Inc. from 2018-2021, …See details»
Robert M. Kotin - Scientific Advisor at Apic Bio - The Org
Scientific Advisor at Apic Bio Contact Dr. Robert Kotin has been a leader in adeno-associated virus (AAV) research for over 30 years, beginning as a post-doctoral fellow at Cornell …See details»
APB-103 - Drug Targets, Indications, Patents - Synapse - Patsnap
APB-103, Initially developed by Apic Bio, Inc., Now, its global highest R&D status is Discovery, Therapeutic Areas: Congenital Disorders,Digestive System Disorders,Respiratory Diseases, …See details»
APB-104 - Drug Targets, Indications, Patents - Synapse - Patsnap
2 days ago APB-104: a C9orf72 gene modulators Drug, Initially developed by Apic Bio, Inc., Now, its global highest R&D status is Preclinical, Mechanism: C9orf72 gene modulators, …See details»
uniQure and Apic Bio enter into global licensing agreement
Jan 31, 2023 Apic Bio is an innovative gene therapy company focused on developing first-in-class treatment options for rare, undertreated neurological and liver diseases. The Company’s …See details»
uniQure signs licence deal for Apic Bio’s gene therapy for ALS
May 10, 2023 Gene therapy company UniQure has entered a global licensing agreement with Apic Bio for APB-102 to treat patients with amyotrophic lateral sclerosis (ALS) caused by …See details»
UniQure snags rare ALS therapy from Apic Bio for $10M upfront
Jan 31, 2023 The Apic Bio pact is the first glimpse at uniQure’s larger business strategy since it nabbed FDA approval for the CSL Behring-partnered hemophilia B therapy Hemgenix in …See details»
Clinical Trial of Gene Therapy for Familial ALS, APB-102, Cleared...
May 17, 2021 “ALS is a devastating, fatal neurogenerative disorder, where mutations in the SOD1 gene account for one-fifth of all inherited forms of the disease,” said Jorge Quiroz, chief …See details»
罕见病信息网 - raredisease.cn
Feb 2, 2023 Apic Bio是一家创新的基因治疗公司，专注于为罕见的，治疗不足的神经系统和肝脏疾病开发一流的治疗方案。 除主要项目APB-102外，公司正在推进几种新型基因疗法，以治 …See details»
uniQure and Apic Bio enter into global licensing agreement for …
Jan 31, 2023 uniQure and Apic Bio enter into global licensing agreement for APB-102, a clinical stage gene therapy for patients with ALS caused by mutations in SOD1 uniQure Inc. Tue, Jan …See details»
APIC Statement on Trump Administration’s Potential Withdrawal …
Arlington, VA – The Association for Professionals in Infection Control and Epidemiology (APIC), the leading association for infection prevention and control (IPC) professionals, expresses …See details»